These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 626988

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Increased therapeutic efficacy and reduced toxicity of doxorubicin linked to pyran copolymer via the side chain of the drug.
    Zunino F, Pratesi G, Pezzoni G.
    Cancer Treat Rep; 1987 Apr; 71(4):367-73. PubMed ID: 3829013
    [Abstract] [Full Text] [Related]

  • 23. Combined therapy of mice bearing L1210 leukemia with adriamycin and mycobacteria.
    Fiszer L, Mordarski M.
    Arch Immunol Ther Exp (Warsz); 1978 Apr; 26(1-6):873-9. PubMed ID: 749836
    [Abstract] [Full Text] [Related]

  • 24. [Models of preclinical studies of anthracyclines].
    Fizames C.
    Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
    [Abstract] [Full Text] [Related]

  • 25. Effects of combined treatment of L1210 leukemia with adriamycin and pustulan.
    Fiszer-Maliszewska L, Mordarski M.
    Arch Immunol Ther Exp (Warsz); 1981 Jan; 29(6):703-10. PubMed ID: 7349092
    [Abstract] [Full Text] [Related]

  • 26. [Antitumor activities of orally administered 7-con-0-methylnogarol (TUT-7)].
    Sugimoto Y, Matsuo K, Takeda S, Yamada Y, Tsukagoshi S.
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):353-8. PubMed ID: 2138003
    [Abstract] [Full Text] [Related]

  • 27. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT, Johnson RK, Kline I, Vadlamudi S, Gang M, Venditti JM, Goldin A.
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [Abstract] [Full Text] [Related]

  • 28. Antitumor activities of (2"R)-4'-O-tetrahydropyranyl-adriamycin (THP) and its combination with other antitumor agents on murine tumors.
    Matsushita Y, Kumagai H, Yoshimoto A, Tone H, Ishikura T, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1985 Oct; 38(10):1408-19. PubMed ID: 4066493
    [Abstract] [Full Text] [Related]

  • 29. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T, Yusa K, Sudo Y, Takamori R, Sugimoto Y.
    Cancer Res; 1989 Oct 15; 49(20):5537-42. PubMed ID: 2790778
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC, Schurig JE, Huftalen JB, Bradner WT.
    Cancer Res; 1983 Apr 15; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract] [Full Text] [Related]

  • 32. Antileukemic activity of 4-demethoxydaunorubicin in mice.
    Casazza AM, Pratesi G, Giuliani F, Di Marco A.
    Tumori; 1980 Oct 31; 66(5):549-64. PubMed ID: 6936969
    [Abstract] [Full Text] [Related]

  • 33. Protein-associated DNA breaks and DNA-protein cross-links caused by DNA nonbinding derivatives of adriamycin in L1210 cells.
    Levin M, Silber R, Israel M, Goldfeder A, Khetarpal VK, Potmesil M.
    Cancer Res; 1981 Mar 31; 41(3):1006-10. PubMed ID: 7459847
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Potentiation by vitamin A of the action of anticancer agents against murine tumors.
    Nakagawa M, Yamaguchi T, Ueda H, Shiraishi N, Komiyama S, Akiyama S, Ogata J, Kuwano M.
    Jpn J Cancer Res; 1985 Sep 31; 76(9):887-94. PubMed ID: 3932288
    [Abstract] [Full Text] [Related]

  • 40. Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.
    Mantovani A, Polentarutti N, Luini W, Peri G, Spreafico F.
    J Natl Cancer Inst; 1979 Jul 31; 63(1):61-6. PubMed ID: 286835
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.